Mirtazapine

Product NDC
50090-1057
11-digit product format
500901057
Labeler code
50090
Product ID
50090-1057_d395de56-30b0-499f-93f6-116e1fd8c26c
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Mirtazapine
Dosage form
TABLET, FILM COATED
Route
ORAL
Labeler
A-S Medication Solutions
Application
ANDA076921
Marketing category
ANDA
Marketing start
2009-08-17
Marketing end
0000-00-00
Substance
MIRTAZAPINE
Active strength
30 mg/1
NDC exclude flag
No
Listing certified through
2022-12-31
Current FDA listing
Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 5 matching rows.

Dataset, Scope, Product NDC table
DatasetScopeProduct NDCPackage NDCCodeStatusReporting periodSource date
excluded productproduct50090-1057DDiscontinued by firm2026-10-16
excluded packagepackage50090-105750090-1057-0DDiscontinued by firm2026-10-16
excluded packagepackage50090-105750090-1057-1DDiscontinued by firm2026-10-16
excluded packagepackage50090-105750090-1057-2DDiscontinued by firm2026-10-16
excluded packagepackage50090-105750090-1057-3DDiscontinued by firm2026-10-16

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 20 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source dateDatasetScopePackage NDCSnapshotSource SHA-256
2025-12-14 17:58 UTC · source 2025-12-05excluded productproductd630ba8d3edf…732f749b63fb…
2025-12-14 17:58 UTC · source 2025-12-05excluded packagepackage50090-1057-3d630ba8d3edf…732f749b63fb…
2025-12-14 17:58 UTC · source 2025-12-05excluded packagepackage50090-1057-2d630ba8d3edf…732f749b63fb…
2025-12-14 17:58 UTC · source 2025-12-05excluded packagepackage50090-1057-1d630ba8d3edf…732f749b63fb…
2025-12-14 17:58 UTC · source 2025-12-05excluded packagepackage50090-1057-0d630ba8d3edf…732f749b63fb…
2025-08-27 00:01 UTC · source 2025-08-26excluded productproductf5e01cc5f278…a2eaf40c39c3…
2025-08-27 00:01 UTC · source 2025-08-26excluded packagepackage50090-1057-3f5e01cc5f278…a2eaf40c39c3…
2025-08-27 00:01 UTC · source 2025-08-26excluded packagepackage50090-1057-2f5e01cc5f278…a2eaf40c39c3…
2025-08-27 00:01 UTC · source 2025-08-26excluded packagepackage50090-1057-1f5e01cc5f278…a2eaf40c39c3…
2025-08-27 00:01 UTC · source 2025-08-26excluded packagepackage50090-1057-0f5e01cc5f278…a2eaf40c39c3…
2025-04-01 02:39 UTC · source 2025-03-31excluded packagepackage50090-1057-02ef7874e63bc…57b86245f4fa…
2025-03-28 20:22 UTC · source 2025-03-28excluded packagepackage50090-1057-0a1b67e2a42f9…c4cf2c586c0d…
2025-03-22 03:12 UTC · source 2025-03-21excluded packagepackage50090-1057-0cfe11265f3b6…090c488252e2…
2025-03-10 12:48 UTC · source 2025-03-10excluded packagepackage50090-1057-0cdf11ea48f46…ba0047e9e063…
2025-02-02 03:52 UTC · source 2025-01-31excluded packagepackage50090-1057-0302b2466d912…e7b80fea0513…
2025-01-20 13:05 UTC · source 2025-01-20excluded packagepackage50090-1057-0ed331223b511…672a5bd82f5f…
2025-01-11 03:41 UTC · source 2025-01-10excluded packagepackage50090-1057-00efc9e666f02…f202fb6c5f17…
2024-11-09 02:27 UTC · source 2024-11-08excluded packagepackage50090-1057-0ad56d346431e…cc804d4bbf1e…
2024-10-04 04:10 UTC · source 2024-10-03excluded packagepackage50090-1057-0367a005e9d99…383a685ebd0f…
2024-07-10 04:00 UTC · source 2024-07-09excluded packagepackage50090-1057-0557ba5c1ecfa…9c80585c8c6e…

Source provenance: Browse the complete Orange Book source catalog · source snapshot 44.

Orange Book products#

Current product rows page 1 of 1 · 4 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A076921-001MIRTAZAPINEMIRTAZAPINE7.5MGTABLET / ORALAB2004-10-22
A076921-002MIRTAZAPINEMIRTAZAPINE15MGTABLET / ORALAB2004-10-22
A076921-003MIRTAZAPINEMIRTAZAPINE30MGTABLET / ORALAB2004-10-22
A076921-004MIRTAZAPINEMIRTAZAPINE45MGTABLET / ORALAB2004-10-22

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 4 matching rows.

Application-product, TE code table
Application-productTE code
A076921-001AB
A076921-002AB
A076921-003AB
A076921-004AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 5 · 176 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-10-15 13:18:302026-09A076921-001MIRTAZAPINE7.5MGTABLET / ORALAB2004-10-22c2088c7a36db…
2026-10-15 13:18:302026-09A076921-002MIRTAZAPINE15MGTABLET / ORALAB2004-10-22c2088c7a36db…
2026-10-15 13:18:302026-09A076921-003MIRTAZAPINE30MGTABLET / ORALAB2004-10-22c2088c7a36db…
2026-10-15 13:18:302026-09A076921-004MIRTAZAPINE45MGTABLET / ORALAB2004-10-22c2088c7a36db…
2026-09-14 22:38:342026-08A076921-001MIRTAZAPINE7.5MGTABLET / ORALAB2004-10-2284e616aacf4f…
2026-09-14 22:38:342026-08A076921-002MIRTAZAPINE15MGTABLET / ORALAB2004-10-2284e616aacf4f…
2026-09-14 22:38:342026-08A076921-003MIRTAZAPINE30MGTABLET / ORALAB2004-10-2284e616aacf4f…
2026-09-14 22:38:342026-08A076921-004MIRTAZAPINE45MGTABLET / ORALAB2004-10-2284e616aacf4f…
2026-08-18 06:07:402026-07A076921-001MIRTAZAPINE7.5MGTABLET / ORALAB2004-10-22caaa826d4ba7…
2026-08-18 06:07:402026-07A076921-002MIRTAZAPINE15MGTABLET / ORALAB2004-10-22caaa826d4ba7…
2026-08-18 06:07:402026-07A076921-003MIRTAZAPINE30MGTABLET / ORALAB2004-10-22caaa826d4ba7…
2026-08-18 06:07:402026-07A076921-004MIRTAZAPINE45MGTABLET / ORALAB2004-10-22caaa826d4ba7…
2026-02-19 14:30 UTC2026-02A076921-001MIRTAZAPINE7.5MGTABLET / ORALAB2004-10-22011fe1cb6892…
2026-02-19 14:30 UTC2026-02A076921-002MIRTAZAPINE15MGTABLET / ORALAB2004-10-22011fe1cb6892…
2026-02-19 14:30 UTC2026-02A076921-003MIRTAZAPINE30MGTABLET / ORALAB2004-10-22011fe1cb6892…
2026-02-19 14:30 UTC2026-02A076921-004MIRTAZAPINE45MGTABLET / ORALAB2004-10-22011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A076921-001MIRTAZAPINE7.5MGTABLET / ORALAB2004-10-2231067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A076921-002MIRTAZAPINE15MGTABLET / ORALAB2004-10-2231067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A076921-003MIRTAZAPINE30MGTABLET / ORALAB2004-10-2231067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A076921-004MIRTAZAPINE45MGTABLET / ORALAB2004-10-2231067a03dcf5…
2025-08-23 18:47 UTC2025-08A076921-001MIRTAZAPINE7.5MGTABLET / ORALAB2004-10-226a471c1ec25d…
2025-08-23 18:47 UTC2025-08A076921-002MIRTAZAPINE15MGTABLET / ORALAB2004-10-226a471c1ec25d…
2025-08-23 18:47 UTC2025-08A076921-003MIRTAZAPINE30MGTABLET / ORALAB2004-10-226a471c1ec25d…
2025-08-23 18:47 UTC2025-08A076921-004MIRTAZAPINE45MGTABLET / ORALAB2004-10-226a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A076921-001MIRTAZAPINE7.5MGTABLET / ORALAB2004-10-22fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A076921-002MIRTAZAPINE15MGTABLET / ORALAB2004-10-22fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A076921-003MIRTAZAPINE30MGTABLET / ORALAB2004-10-22fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A076921-004MIRTAZAPINE45MGTABLET / ORALAB2004-10-22fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A076921-001MIRTAZAPINE7.5MGTABLET / ORALAB2004-10-22b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A076921-002MIRTAZAPINE15MGTABLET / ORALAB2004-10-22b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A076921-003MIRTAZAPINE30MGTABLET / ORALAB2004-10-22b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A076921-004MIRTAZAPINE45MGTABLET / ORALAB2004-10-22b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A076921-001MIRTAZAPINE7.5MGTABLET / ORALAB2004-10-2203ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A076921-002MIRTAZAPINE15MGTABLET / ORALAB2004-10-2203ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A076921-003MIRTAZAPINE30MGTABLET / ORALAB2004-10-2203ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A076921-004MIRTAZAPINE45MGTABLET / ORALAB2004-10-2203ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A076921-001MIRTAZAPINE7.5MGTABLET / ORALAB2004-10-222680178bc6a6…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A076921-002MIRTAZAPINE15MGTABLET / ORALAB2004-10-222680178bc6a6…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A076921-003MIRTAZAPINE30MGTABLET / ORALAB2004-10-222680178bc6a6…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A076921-004MIRTAZAPINE45MGTABLET / ORALAB2004-10-222680178bc6a6…

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 5 · 176 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2026-10-15 13:18:302026-09A076921-001AB1c2088c7a36db…
2026-10-15 13:18:302026-09A076921-002AB1c2088c7a36db…
2026-10-15 13:18:302026-09A076921-003AB1c2088c7a36db…
2026-10-15 13:18:302026-09A076921-004AB1c2088c7a36db…
2026-09-14 22:38:342026-08A076921-001AB184e616aacf4f…
2026-09-14 22:38:342026-08A076921-002AB184e616aacf4f…
2026-09-14 22:38:342026-08A076921-003AB184e616aacf4f…
2026-09-14 22:38:342026-08A076921-004AB184e616aacf4f…
2026-08-18 06:07:402026-07A076921-001AB1caaa826d4ba7…
2026-08-18 06:07:402026-07A076921-002AB1caaa826d4ba7…
2026-08-18 06:07:402026-07A076921-003AB1caaa826d4ba7…
2026-08-18 06:07:402026-07A076921-004AB1caaa826d4ba7…
2026-02-19 14:30 UTC2026-02A076921-001AB1011fe1cb6892…
2026-02-19 14:30 UTC2026-02A076921-002AB1011fe1cb6892…
2026-02-19 14:30 UTC2026-02A076921-003AB1011fe1cb6892…
2026-02-19 14:30 UTC2026-02A076921-004AB1011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A076921-001AB131067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A076921-002AB131067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A076921-003AB131067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A076921-004AB131067a03dcf5…
2025-08-23 18:47 UTC2025-08A076921-001AB16a471c1ec25d…
2025-08-23 18:47 UTC2025-08A076921-002AB16a471c1ec25d…
2025-08-23 18:47 UTC2025-08A076921-003AB16a471c1ec25d…
2025-08-23 18:47 UTC2025-08A076921-004AB16a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A076921-001AB1fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A076921-002AB1fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A076921-003AB1fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A076921-004AB1fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A076921-001AB1b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A076921-002AB1b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A076921-003AB1b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A076921-004AB1b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A076921-001AB103ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A076921-002AB103ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A076921-003AB103ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A076921-004AB103ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A076921-001AB12680178bc6a6…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A076921-002AB12680178bc6a6…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A076921-003AB12680178bc6a6…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A076921-004AB12680178bc6a6…

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
1ca5a24a-fafa-8fc8-52ac-b403ff18faa5Product name320240216
a733d273-402b-1005-9891-1ac1a9c63703Product name220170724

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Related label table
NDCEffectiveRelated label
50090-1057-02023-02-07These highlights do not include all the information needed to use MIRTAZAPINE TABLETS safely and effectively. See full prescribing information for MIRTAZAPINE TABLETS. MIRTAZAPINE tablets, for oral use Initial U.S. Approval: 1996
50090-1057-02023-02-07These highlights do not include all the information needed to use MIRTAZAPINE TABLETS safely and effectively. See full prescribing information for MIRTAZAPINE TABLETS. MIRTAZAPINE tablets, for oral use Initial U.S. Approval: 1996
50090-1057-02023-02-07These highlights do not include all the information needed to use MIRTAZAPINE TABLETS safely and effectively. See full prescribing information for MIRTAZAPINE TABLETS. MIRTAZAPINE tablets, for oral use Initial U.S. Approval: 1996
50090-1057-12023-02-07These highlights do not include all the information needed to use MIRTAZAPINE TABLETS safely and effectively. See full prescribing information for MIRTAZAPINE TABLETS. MIRTAZAPINE tablets, for oral use Initial U.S. Approval: 1996
50090-1057-12023-02-07These highlights do not include all the information needed to use MIRTAZAPINE TABLETS safely and effectively. See full prescribing information for MIRTAZAPINE TABLETS. MIRTAZAPINE tablets, for oral use Initial U.S. Approval: 1996
50090-1057-12023-02-07These highlights do not include all the information needed to use MIRTAZAPINE TABLETS safely and effectively. See full prescribing information for MIRTAZAPINE TABLETS. MIRTAZAPINE tablets, for oral use Initial U.S. Approval: 1996
50090-1057-22023-02-07These highlights do not include all the information needed to use MIRTAZAPINE TABLETS safely and effectively. See full prescribing information for MIRTAZAPINE TABLETS. MIRTAZAPINE tablets, for oral use Initial U.S. Approval: 1996
50090-1057-22023-02-07These highlights do not include all the information needed to use MIRTAZAPINE TABLETS safely and effectively. See full prescribing information for MIRTAZAPINE TABLETS. MIRTAZAPINE tablets, for oral use Initial U.S. Approval: 1996
50090-1057-22023-02-07These highlights do not include all the information needed to use MIRTAZAPINE TABLETS safely and effectively. See full prescribing information for MIRTAZAPINE TABLETS. MIRTAZAPINE tablets, for oral use Initial U.S. Approval: 1996
50090-1057-32023-02-07These highlights do not include all the information needed to use MIRTAZAPINE TABLETS safely and effectively. See full prescribing information for MIRTAZAPINE TABLETS. MIRTAZAPINE tablets, for oral use Initial U.S. Approval: 1996
50090-1057-32023-02-07These highlights do not include all the information needed to use MIRTAZAPINE TABLETS safely and effectively. See full prescribing information for MIRTAZAPINE TABLETS. MIRTAZAPINE tablets, for oral use Initial U.S. Approval: 1996
50090-1057-32023-02-07These highlights do not include all the information needed to use MIRTAZAPINE TABLETS safely and effectively. See full prescribing information for MIRTAZAPINE TABLETS. MIRTAZAPINE tablets, for oral use Initial U.S. Approval: 1996
50090-1057-02023-01-30These highlights do not include all the information needed to use MIRTAZAPINE TABLETS safely and effectively. See full prescribing information for MIRTAZAPINE TABLETS. MIRTAZAPINE tablets, for oral use Initial U.S. Approval: 1996
50090-1057-02023-01-30These highlights do not include all the information needed to use MIRTAZAPINE TABLETS safely and effectively. See full prescribing information for MIRTAZAPINE TABLETS. MIRTAZAPINE tablets, for oral use Initial U.S. Approval: 1996
50090-1057-02023-01-30These highlights do not include all the information needed to use MIRTAZAPINE TABLETS safely and effectively. See full prescribing information for MIRTAZAPINE TABLETS. MIRTAZAPINE tablets, for oral use Initial U.S. Approval: 1996
50090-1057-12023-01-30These highlights do not include all the information needed to use MIRTAZAPINE TABLETS safely and effectively. See full prescribing information for MIRTAZAPINE TABLETS. MIRTAZAPINE tablets, for oral use Initial U.S. Approval: 1996
50090-1057-12023-01-30These highlights do not include all the information needed to use MIRTAZAPINE TABLETS safely and effectively. See full prescribing information for MIRTAZAPINE TABLETS. MIRTAZAPINE tablets, for oral use Initial U.S. Approval: 1996
50090-1057-12023-01-30These highlights do not include all the information needed to use MIRTAZAPINE TABLETS safely and effectively. See full prescribing information for MIRTAZAPINE TABLETS. MIRTAZAPINE tablets, for oral use Initial U.S. Approval: 1996
50090-1057-22023-01-30These highlights do not include all the information needed to use MIRTAZAPINE TABLETS safely and effectively. See full prescribing information for MIRTAZAPINE TABLETS. MIRTAZAPINE tablets, for oral use Initial U.S. Approval: 1996
50090-1057-22023-01-30These highlights do not include all the information needed to use MIRTAZAPINE TABLETS safely and effectively. See full prescribing information for MIRTAZAPINE TABLETS. MIRTAZAPINE tablets, for oral use Initial U.S. Approval: 1996
50090-1057-22023-01-30These highlights do not include all the information needed to use MIRTAZAPINE TABLETS safely and effectively. See full prescribing information for MIRTAZAPINE TABLETS. MIRTAZAPINE tablets, for oral use Initial U.S. Approval: 1996
50090-1057-32023-01-30These highlights do not include all the information needed to use MIRTAZAPINE TABLETS safely and effectively. See full prescribing information for MIRTAZAPINE TABLETS. MIRTAZAPINE tablets, for oral use Initial U.S. Approval: 1996
50090-1057-32023-01-30These highlights do not include all the information needed to use MIRTAZAPINE TABLETS safely and effectively. See full prescribing information for MIRTAZAPINE TABLETS. MIRTAZAPINE tablets, for oral use Initial U.S. Approval: 1996
50090-1057-32023-01-30These highlights do not include all the information needed to use MIRTAZAPINE TABLETS safely and effectively. See full prescribing information for MIRTAZAPINE TABLETS. MIRTAZAPINE tablets, for oral use Initial U.S. Approval: 1996

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
50090-1057-0Mirtazapine30 in 1 BOTTLETABLET, FILM COATED3021
50090-1057-1Mirtazapine15 in 1 BOTTLETABLET, FILM COATED1521
50090-1057-2Mirtazapine60 in 1 BOTTLETABLET, FILM COATED6021
50090-1057-3Mirtazapine90 in 1 BOTTLETABLET, FILM COATED9021

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
50090-1057-0EA - Each50090-105731119181-8e75-45c0-9553-b385c5b16a0c12021-08-05
50090-1057-2EA - Each50090-1057f0e52f93-0f0c-49c3-8c34-2a76910447ec12021-08-05
50090-1057-3EA - Each50090-1057276cf4f1-d453-44ec-8a03-12a6a429a41c12021-08-05

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
50090-1057MIRTAZAPINE TABLET, FILM COATED [A-S MEDICATION SOLUTIONS]16Legacy NDC, 4 package rows20230208_67e753ad-9919-416b-9e8f-aab0fa808066.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 2 of 3 · 44 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
MirtazapineMIRTAZAPINEBryant Ranch Prepack7727fe84-f6cc-4b31-bc00-1ecf741ad3612026-01-23Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (ANDA): 076921
application number: ANDA076921
MirtazapineMIRTAZAPINEREMEDYREPACK INC.d1b59d87-8442-4c15-8bb9-e39b198d86772026-01-08Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (ANDA): 076921
application number: ANDA076921
MirtazapineMIRTAZAPINEBryant Ranch Prepackc2b38cc5-7738-44fa-9bef-89a18a1039b22025-12-03Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (ANDA): 076921
application number: ANDA076921
MirtazapineMIRTAZAPINEBryant Ranch Prepack1cc1a159-11ec-4040-817b-d57fa827a7732025-11-21Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (ANDA): 076921
application number: ANDA076921
MirtazapineMIRTAZAPINEBryant Ranch Prepack1fb26f9b-b075-471d-8cc3-fa39246ec2e42025-11-19Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (ANDA): 076921
application number: ANDA076921
MirtazapineMIRTAZAPINEBryant Ranch Prepackbeaa0678-e4b9-4241-8b08-e69e2e49530f2025-11-18Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (ANDA): 076921
application number: ANDA076921
MirtazapineMIRTAZAPINEBryant Ranch Prepackbd532a25-cfde-4c7d-8015-ba40609fb95c2025-11-17Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (ANDA): 076921
application number: ANDA076921
MirtazapineMIRTAZAPINEBryant Ranch Prepackd0cda063-00c5-0921-ee39-d4de1381f91a2025-11-10Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (ANDA): 076921
application number: ANDA076921
MirtazapineMIRTAZAPINEBryant Ranch Prepack55c5905c-6cb8-4ed4-8e69-97f733ca91b52025-11-04Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (ANDA): 076921
application number: ANDA076921
MirtazapineMIRTAZAPINERising Pharma Holdings, Inc.58e9b4c6-531f-49c4-a640-6953e70892fe2025-09-12Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (ANDA): 076921
application number: ANDA076921
MirtazapineMIRTAZAPINEAurolife Pharma LLCaa05d606-29fd-443e-802b-1d65584d6bb12025-09-10Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (ANDA): 076921
application number: ANDA076921
MirtazapineMIRTAZAPINEAurobindo Pharma Limiteda4c012f0-50b6-42fb-9f06-a14632f23f2e2025-07-19Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (ANDA): 076921
application number: ANDA076921
MirtazapineMIRTAZAPINEATLANTIC BIOLOGICALS CORP.e6e5cbf7-a958-4ef8-abcc-a7491edb95202025-06-27Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (ANDA): 076921
application number: ANDA076921
MirtazapineMIRTAZAPINEDirect_Rx3699b988-6d9a-dcc1-e063-6394a90ab38d2025-06-02Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (ANDA): 076921
application number: ANDA076921
MirtazapineMIRTAZAPINENorthStar Rx LLC979eec8b-1bf4-466b-812e-85a111ce1cb52025-02-24Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (ANDA): 076921
application number: ANDA076921
MirtazapineMIRTAZAPINEAmerican Health Packaging3b7a5f44-8da6-4196-bb5d-8d2770af1b3a2025-01-07Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (ANDA): 076921
application number: ANDA076921
MirtazapineMIRTAZAPINEAdvanced Rx Pharmacy of Tennessee, LLCf8c383c1-d1b3-ceaa-e053-6294a90a60532024-12-31Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (ANDA): 076921
application number: ANDA076921
MirtazapineMIRTAZAPINENuCare Pharmaceuticals,Inc.8e839bb2-2f67-f224-e053-2a95a90ae5d82024-06-18Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (ANDA): 076921
application number: ANDA076921
MirtazapineMIRTAZAPINENCS HealthCare of KY, LLC dba Vangard Labs70439462-b632-4d21-8067-560162db31372023-09-18Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (ANDA): 076921
application number: ANDA076921
MirtazapineMIRTAZAPINEProficient Rx LP0f19ab40-1a30-4ac2-9bd7-c2f8199e29e12022-08-01Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (ANDA): 076921
application number: ANDA076921

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
311725mirtazapine 15 MG Oral TabletPSN67e753ad-9919-416b-9e8f-aab0fa80806621
314111mirtazapine 30 MG Oral TabletPSN67e753ad-9919-416b-9e8f-aab0fa80806621
311725mirtazapine 15 MG Oral TabletSCD67e753ad-9919-416b-9e8f-aab0fa80806621
314111mirtazapine 30 MG Oral TabletSCD67e753ad-9919-416b-9e8f-aab0fa80806621

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionMarketing startMarketing endSampleExclude flagStatus
50090-1057-05009010570030 TABLET, FILM COATED in 1 BOTTLE (50090-1057-0) 2014-11-280000-00-00NoNoCurrent
50090-1057-15009010570115 TABLET, FILM COATED in 1 BOTTLE (50090-1057-1) 2019-10-290000-00-00NoNoCurrent
50090-1057-25009010570260 TABLET, FILM COATED in 1 BOTTLE (50090-1057-2) 2014-11-280000-00-00NoNoCurrent
50090-1057-35009010570390 TABLET, FILM COATED in 1 BOTTLE (50090-1057-3) 2014-11-280000-00-00NoNoCurrent